AbbVie tops doctor ranking of immunology companies, handily beating Pfizer and J&J

Doctors overwhelmingly consider AbbVie as the leading company in the immunology space, its reputation bolstered by its top-selling drugs Humira (adalimumab) and Skyrizi (risankizumab), according to a new report by healthcare consulting firm ZoomRx.